中国P站

Immunometabolism; Glucose Metabolism; Lipid Metabolism; Mitochondria; Immune Cell Function; Gut Microbiota; Nutrient Sensing Pathways; Cancer; Inflammatory Diseases; Aging

Introduction

Metabolic reprogramming is fundamental to immune cell function, dictating their differentiation, activation, and effector capabilities. This intricate interplay between metabolism and immunity, aptly termed immunometabolism, is critical for orchestrating appropriate responses to pathogens and maintaining tissue homeostasis. Recent scientific advances highlight how specific metabolic pathways fuel distinct immune cell subsets and how dysregulation of these pathways contributes significantly to the progression of inflammatory diseases and cancer. Glucose metabolism, particularly glycolysis, emerges as a primary driver for activated immune cells, furnishing them with essential building blocks and ATP necessary for rapid proliferation and robust effector functions. However, it is important to note that the specific metabolic demands can vary significantly depending on the immune cell type and its functional state, with oxidative phosphorylation also playing crucial roles in the long-lived memory cells and certain regulatory functions. The intricate relationship between mitochondrial function and immune responses is increasingly recognized in the scientific community. Mitochondria are not merely passive powerhouses but also serve as dynamic hubs for critical signaling events, reactive oxygen species production, and essential metabolite synthesis, all of which profoundly influence immune cell fate and function, including the crucial generation of effector and memory T cells. Lipid metabolism plays an indispensable role in immune cell differentiation and function, particularly evident in the development of macrophages and T helper cells. The synthesis, uptake, and oxidation of fatty acids are tightly regulated processes that significantly impact inflammatory responses, contributing to the pathogenesis of various autoimmune diseases and metabolic disorders. The gut microbiota exerts a substantial influence on host immunometabolism, effectively shaping immune cell development and function both within the gut-associated lymphoid tissue and systemically. Microbial metabolites, such as short-chain fatty acids SCFAs, directly impact T cell differentiation and function, thereby influencing the course of inflammatory and metabolic diseases. Metabolic adaptation of immune cells is paramount for the execution of their effector functions and overall longevity. For instance, effector T cells rely heavily on glycolysis for rapid ATP production, while memory T cells often switch to oxidative phosphorylation for sustained energy supply and long-term survival, clearly demonstrating distinct metabolic profiles that correspond to different immune states. The role of immunometabolism within the tumor microenvironment is multifaceted and complex. Tumors are known to create a unique microenvironment that often exploits the metabolic pathways of immune cells, leading to the impairment of anti-tumor immunity. A deeper understanding of these metabolic adaptations holds the potential to unlock novel therapeutic strategies specifically targeting tumor-associated immune cells. Immune cells implicated in the pathogenesis of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, consistently exhibit distinct metabolic profiles. Targeting these specific metabolic vulnerabilities offers a promising avenue for the development of novel immunomodulatory therapies that may possess fewer side effects compared to broader immunosuppressants. Nutrient sensing pathways, including prominent examples like mTOR and AMP-activated protein kinase AMPK, function as central regulators of immune cell metabolism. These critical pathways effectively integrate signals from the cellular environment to precisely control metabolic flux and dictate the resultant immune cell responses, positioning them as key targets for therapeutic intervention. The interplay between immunometabolism and the process of aging represents a critical and actively researched area. Metabolic changes that naturally accompany aging can significantly impair immune cell function, contributing to immunosenescence and an increased susceptibility to infections and age-related diseases. Consequently, modulating immunometabolism could offer viable strategies to enhance immune function in the elderly population.

Description

Metabolic reprogramming is a foundational process for immune cell function, profoundly influencing their differentiation, activation, and effector capabilities. This dynamic interplay, known as immunometabolism, is essential for mounting effective responses against pathogens and maintaining tissue homeostasis. Emerging research underscores how specific metabolic pathways provide the necessary fuel for distinct immune cell subsets and how disruptions in these pathways contribute to inflammatory diseases and cancer. Activated immune cells primarily utilize glucose metabolism, especially glycolysis, to generate ATP and essential building blocks required for rapid proliferation and effector functions. However, metabolic needs are not uniform; they vary considerably based on immune cell type and functional status. Oxidative phosphorylation also plays a significant role, particularly in sustaining long-lived memory cells and specific regulatory functions. There is growing recognition of the critical link between mitochondrial function and immune responses. Mitochondria are more than just energy producers; they are central to signaling pathways, the generation of reactive oxygen species, and the synthesis of metabolites, all of which significantly impact immune cell fate and function, including the development of effector and memory T cells. Lipid metabolism is crucial for the differentiation and function of immune cells, notably macrophages and T helper cells. The processes of fatty acid synthesis, uptake, and oxidation are tightly regulated, influencing inflammatory responses and contributing to the development of autoimmune and metabolic disorders. The gut microbiota plays a significant role in host immunometabolism, shaping the development and function of immune cells within the gut-associated lymphoid tissue and throughout the body. Microbial metabolites, such as short-chain fatty acids SCFAs, directly influence T cell differentiation and function, impacting the course of inflammatory and metabolic diseases. Metabolic adaptation is vital for immune cells to perform their effector functions and achieve long-term survival. Effector T cells depend on glycolysis for rapid ATP production, whereas memory T cells often shift to oxidative phosphorylation for sustained energy and long-term survival, indicating distinct metabolic strategies for different immune states. Immunometabolism has a complex role in cancer. Tumors create a unique microenvironment that leverages the metabolic pathways of immune cells, thereby hindering anti-tumor immunity. Understanding these metabolic adaptations could pave the way for innovative therapeutic strategies aimed at modulating tumor-associated immune cells. Immune cells involved in inflammatory conditions like rheumatoid arthritis and inflammatory bowel disease exhibit specific metabolic profiles. Targeting these metabolic vulnerabilities presents a promising approach for developing new immunomodulatory therapies with potentially fewer side effects than broadly acting immunosuppressants. Nutrient sensing pathways, including mTOR and AMPK, are key regulators of immune cell metabolism. They integrate environmental cues to control metabolic flow and immune cell responses, making them important targets for therapeutic interventions. The interaction between immunometabolism and aging is a significant area of study. Age-related metabolic changes can compromise immune cell function, leading to immunosenescence and increased vulnerability to infections and age-related diseases. Modulating immunometabolism might offer methods to improve immune function in older individuals.

Conclusion

Immunometabolism, the interplay between immune cell function and metabolism, is crucial for immune responses and tissue homeostasis. Key metabolic pathways like glycolysis and oxidative phosphorylation are vital for immune cell activation, differentiation, and memory formation, with specific needs varying by cell type and state. Mitochondria play multifaceted roles beyond energy production, influencing immune cell fate and function. Lipid metabolism is critical for macrophage and T cell development, impacting inflammatory responses. The gut microbiota significantly influences immunometabolism through metabolites like SCFAs, affecting T cell function and disease pathogenesis. Metabolic adaptations are essential for immune cell effector functions and longevity, with effector and memory T cells exhibiting distinct metabolic profiles. In cancer, tumors exploit immune cell metabolism to evade anti-tumor immunity, presenting therapeutic targets. Inflammatory diseases are characterized by altered immune cell metabolism, suggesting targeted therapies. Nutrient sensing pathways like mTOR and AMPK regulate immune cell metabolism, acting as intervention points. Aging impairs immune cell metabolism, increasing susceptibility to infections and diseases, with metabolic modulation offering potential enhancement strategies for elderly immunity.

References

1. David MG, Brendan DRM, Laura MM. (2021) .Immunology 163:163(3):207-220.

   , ,

2. Rhiannon RM, P CL, G RS. (2020) .Nat Rev Immunol 20:20(6):333-345.

   , ,

3. Maitrayee C, Chih-Jung C, Soumita D. (2022) .Cell 185:185(7):1182-1196.

   , ,

4. Gopesh KJ, P LSR, R KK. (2021) .Immunity 54:54(2):239-257.

   , ,

5. Q ML, Y W, H C. (2022) .Nat Rev Gastroen 19:19(10):684-700.

   , ,

6. R JWvdM, J AvdV, A MvdE. (2020) .J Exp Med 217:217(12):e20200524.

   , ,

7. J LS, E ES, M LS. (2021) .Cancer Cell 39:39(3):334-352.

   , ,

8. V RJP, S JP, A RP. (2022) .Trends Immunol 43:43(8):632-647.

   , ,

9. B BD, A JV, P VTD. (2023) .Nat Rev Mol Cell Bio 24:24(4):284-303.

   , ,

10. S KS, P KS, N KS. (2021) .Aging Cell 20:20(3):e13374.

    , ,